Mingyang Hu
Biographic Data
| ID | 9115271 |
|---|---|
| NAME | Mingyang Hu |
| GIVEN NAMES | Mingyang |
| FAMILY NAME | Hu |
| SIGNATURE | HU M |
| AFFILIATIONS | Sichuan University |
| ORCID | 0009-0004-3647-4141 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China
OBJECTIVE: To develop a multi-stakeholder, consensus-based decision support framework for prioritizing innovative anticancer drugs in Chinese hospital formularies, balancing clinical benefit, patient access, and financial sustainability. METHODS: A two-round Delphi survey was conducted with a multidisciplinary expert panel (n = 62 in Round 1; n = 51 in Round 2, 82.3% retention rate) comprising clinicians, pharmacists, health administrators, and p…
No prominent works on this page.
A Delphi Study to Identify Priority Indicators for Formulary Selection of Innovative Anticancer Drugs in China
OBJECTIVE: To develop a multi-stakeholder, consensus-based decision support framework for prioritizing innovative anticancer drugs in Chinese hospital formularies, balancing clinical benefit, patient access, and financial sustainability. METHODS: A two-round Delphi survey was conducted with a multidisciplinary expert panel (n = 62 in Round 1; n = 51 in Round 2, 82.3% retention rate) comprising clinicians, pharmacists, health administrators, and p…
China (1 works) · Delphi (1 works) · Delphi method (1 works) · Delphi Technique in Research (1 works) · Formulary (1 works) · Health Systems, Economic Evaluations, Quality of Life (1 works) · Medication Adherence and Compliance (1 works) · Selection (genetic algorithm) (1 works)